DELPOR

Delpor, Inc. engages in developing and acquiring drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant. Its technologies include Prozor, which is used for the delivery of antipsychotics and other small molecule drugs from a non-mechanical implantable drug delivery device; NANOPOR, a non-mechanical implantable drug delivery device in which sustained release is provided by membrane architecture; and Delos PUMP, a self-contained and electro-osmotically driven implantable drug delivery device to deliver drugs in predetermined patterns. The company was incorporated in 2009 and is based in San Francisco, California.